Sign In
Buy TCRX
TScan Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 87.71. In total, the insiders bought 30.05M and sold 329.37K TCRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
87.71 |
| ● Buy | 30.05M shares |
| ● Sell | 329.37K shares |
|
98% Buy Activity
Weak Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Aug 14, 2025 Buy |
Dworak Leiden Principal Accounting Officer |
37 500 Value: $108.8K |
||
|
Jun 30, 2025 Buy |
Baker Bros. Advisors Lp Director |
67 000 Value: $97.2K |
||
|
Jun 30, 2025 Buy |
Klencke Barbara Director |
67 000 Value: $97.2K |
||
|
Jun 30, 2025 Buy |
Nicholson Garry A Director |
67 000 Value: $97.2K |
||
|
Jun 30, 2025 Buy |
Woods Keith Director |
67 000 Value: $97.2K |
||
|
Jun 30, 2025 Buy |
Dorton Katina Director |
67 000 Value: $97.2K |
||
|
Jun 30, 2025 Buy |
Gruia Gabriela Director |
67 000 Value: $97.2K |
||
|
Jun 30, 2025 Buy |
Gruia Gabriela Director |
67 000 Value: $97.2K |
||
|
Jun 30, 2025 Buy |
Dorton Katina Director |
67 000 Value: $97.2K |
||
|
Jun 30, 2025 Buy |
Woods Keith Director |
67 000 Value: $97.2K |
||
|
Jun 30, 2025 Buy |
Nicholson Garry A Director |
67 000 Value: $97.2K |
||
|
Jun 30, 2025 Buy |
Klencke Barbara Director |
67 000 Value: $97.2K |
||
|
Jun 30, 2025 Buy |
Baker Bros. Advisors Lp Director |
67 000 Value: $97.2K |
||
|
May 20, 2025 Buy |
Lynx1 Capital Management Lp 10 Percent Owner |
1 200 000 Value: $1.44M |
||
|
May 20, 2025 Buy |
Lynx1 Capital Management Lp 10 Percent Owner |
1 200 000 Value: $1.44M |
||
|
May 19, 2025 Buy |
Lynx1 Capital Management Lp 10 Percent Owner |
1 388 794 Value: $1.67M |
||
|
May 19, 2025 Buy |
Lynx1 Capital Management Lp 10 Percent Owner |
1 388 794 Value: $1.67M |
||
|
Jan 03, 2025 Buy |
Macbeath Gavin Chief Executive Officer |
800 000 Value: $2.45M |
||
|
Jan 03, 2025 Buy |
Amello Jason Chief Financial Officer |
270 000 Value: $827.6K |
||
|
Jan 03, 2025 Buy |
Louis Chrystal Chief Medical Officer |
400 000 Value: $1.23M |
||
|
Jan 03, 2025 Buy |
Zdraveski Zoran See Remarks |
250 000 Value: $766.3K |
||
|
Jan 03, 2025 Buy |
Louis Chrystal Chief Medical Officer |
400 000 Value: $1.23M |
||
|
Jan 03, 2025 Buy |
Amello Jason Chief Financial Officer |
270 000 Value: $827.6K |
||
|
Jan 03, 2025 Buy |
Macbeath Gavin Chief Executive Officer |
800 000 Value: $2.45M |
||
|
Jan 03, 2025 Buy |
Zdraveski Zoran See Remarks |
250 000 Value: $766.3K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
